Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid. Instituto, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Diabetes Res Clin Pract. 2022 Jul;189:109971. doi: 10.1016/j.diabres.2022.109971. Epub 2022 Jun 26.
To assesses the relationship between the wear and tear of therapeutic footwear (TF) and the risk of recurrence in diabetes remission patients.
Remission patients (N = 115) participated in this 5-year prospective study in a specialized Diabetic Foot Unit between October 2016 and January 2022. Patients' TF was assessed in a three-month interval from Day 0 until ulcer recurrence was found. Primary outcome measure was based on the recurrent event in the forefoot.
A total of 82 patients (71.3%) renewed their TF, and 33 patients (28.7%) did not renew their TF during the follow-up period. Patients who failed to renew their TF group experienced more recurrent events (22 vs 14, p <.001, CI [0.04-0.259]) and minor amputations (11 vs 8, p =.002, CI [0.07-0.6]). Both groups showed different recurrence-free survival median times of 205.5 [Interquartile range (IQR) - 188-222] weeks and 89.9 [IQR - 53-126] weeks. Patients who did not renew their TF increased their risk of suffering from a recurrent event in the Cox regression model (p <.001, CI [0.03-0.38], Hazzard Ratio 0.147).
Patients who renewed their TF because of wear and tear experienced lower recurrences and minor amputations.
评估治疗性鞋(TF)的磨损与糖尿病缓解患者复发风险之间的关系。
缓解期患者(N=115)参加了这项为期 5 年的前瞻性研究,该研究于 2016 年 10 月至 2022 年 1 月在专门的糖尿病足科进行。在从第 0 天开始的三个月间隔内评估患者的 TF,直到发现溃疡复发。主要观察指标基于前足的复发性事件。
共有 82 名患者(71.3%)更换了 TF,33 名患者(28.7%)在随访期间未更换 TF。未能更换 TF 组的患者经历了更多的复发事件(22 次与 14 次,p<.001,CI [0.04-0.259])和小截肢(11 次与 8 次,p=.002,CI [0.07-0.6])。两组的无复发生存中位时间分别为 205.5 [四分位距(IQR)-188-222]周和 89.9 [IQR - 53-126]周。在 Cox 回归模型中,未更换 TF 的患者发生复发事件的风险增加(p<.001,CI [0.03-0.38],Hazzard 比 0.147)。
因磨损而更换 TF 的患者复发和小截肢的发生率较低。